Privacy Policy - pharmaLevers

Go to content

Privacy Policy

Terms of Use

The responsible person for every aspects of privacy policy is indicated in the imprint  
pharmaLevers website is encrypted (SSL) - https://www.pharmalevers.com
 
pharmaLevers acknowledge personal rights of being informed, of access, of rectification, of erasure, of restrict processing, of data portability and of not being subject to automated decision-making including profiling  
  
By using pharmaLevers Website (“Site”), Blog and pharmaLevers e-Content Sharing (“e-CS”) you agree to the following Privacy Policy:
 
 
Section 1: Homepage
You should acknowledge that data sent via the Internet can be assessed by unauthorized third parties by criminal activities. pharmaLevers website is encrypted (SSL) - using safe https://www.pharmalevers.com connection. In general, the IP-address is used for sending data from a sender to a receiver; this means your IP-address is used and required to display the Site content. Normally dynamic IP-addresses are used which change several times over 24 hours. pharmaLevers itself does not make efforts to collect and store IP-addresses. However, if required by law, you could be identified based on your IP-address. pharmaLevers is not using google analytics; no tracking code is embedded into the Site. The use of the internet and the Site may generate and use Cookies. pharmaLevers makes no effort to identify, collect, store or use such data. Cookies on pharmaLevers Site are for full functionality. pharmaLevers may collect personal contact information such as personal name, email addresses, company name, address and telephone number. In addition, subject and issue history of requests may also be stored. The input of such personal data and information takes place voluntarily. No such data will be sold or passed to third parties unless required by law. All such personal data will be deleted upon Site user’s written demand.
pharmaLevers Site server is located in the European Community. The prevailing part of the Site’s content is stored there. pharmaLevers is able to analyze aggregated anonymized data for statistical purposes. Such analysis will identify broad location (Country, City), browser, device type, number of visits for a specific page as well as total number of Site visits.
  
The Site features some Rich-Media Content (“RMC”) pages or files (see corresponding pages & files at the end*). RMC pages and files are managed by iSpring Web Services in the USA. iSpring-Clients are companies like IBM, Microsoft, Siemens, Kaspersky and many others. iSpring host providers follow a high standard (ISO 27001 or SSAE 16). For RMC your IP-address is sent to the USA. Your IP-address is not available for admins or reports and only used for content playback. If you are using a Link to RMC, pharmaLevers will track RMC visits in an aggregated anonymized way for statistical reasons. In contrast, if you are invited to view RMC by a personal email, your Email-address, personal visits and downloads will be tracked.
  
pharmaLevers Site is using Twitter as a Social Media Plugin. If you login to Twitter its privacy policy is getting valid. If you click on one of pharmaLevers Tweets (News page), you enter the Twitter system and you will be redirected to an external landing page according to the corresponding link. In such a case the privacy policy of the landing page is getting valid. This holds true for all redirected links on the Site.
 
*The following pages & files are Rich-Media Content (RMC):
Glossary, Market Access Quiz, any e-learning content
 
 
Blog
pharmaLevers (the responsible person) acts as administrator for the Market Access blog. The blog is based on WordPress and its Privacy Policy applies: quote "all of the information that is collected on WordPress.org will be handled in accordance with GDPR legislation". pharmaLevers is storing your name and Email address. You can manage your profile and posts. You can ask for exportation of your data. Your posts and your account can be deleted upon request at any time.
 
 
Section 2: e-Content Sharing (e-CS)
pharmaLevers newsletters provide specific information on market access issues in the area of pricing & reimbursement, health economy, HTA and policy for the life science industry, payers and decision makers. The newsletters can also contain information on pharmaLevers offered services in this field.
  
pharmaLevers is using MailChimp as provider to manage Newsletters. Newsletter subsriptions follows double opt-in procedure. MailChimp is based in the US and its privacy policy (i.a. 5.E.) is valid. Your Email- and IP-address as well the optional mention of your name will be stored in the US by MailChimp. MailChimp participates in and has certified its compliance with the EU-U.S. Privacy Shield Framework (see privacy policy Section 5.E.). MailChimp is using Cookies and is tracking user activities for statistical analysis (web-beacon) and to learn from reading habits (e.g. which links were clicked). pharmaLevers has not activated google analytics. You as a subscriber has the right to unsubscribe form the newsletter at any time.
 
Newsletters frequently contain links to Rich-Media Content (“RMC”) pages or files. RMC pages and files are managed by iSpring Web Services in the USA. iSpring-Clients are companies like IBM, Microsoft, Siemens, Kaspersky and many others. iSpring host providers follow a high standard (ISO 27001 or SSAE 16). For RMC your IP-address is sent to the USA. Your IP-address is not available for admins or reports and only used for content playback. If you are using a Link to RMC, pharmaLevers will track RMC visits in an aggregated anonymized way for statistical reasons. In contrast, if you are invited to view RMC by a personal email, your Email-address, personal visits and downloads will be tracked.
 
pharmaLevers newsletters are using Twitter and Linkedin as Social Media Plugins. If you are login to Twitter or Linkedin their privacy policies are getting valid.



Back to content